Diabetic retinopathy (DR) is the major ocular complication of diabetes mellitus, and is a
problem with significant global health impact. Major advances in diagnostics, technology …

Diabetic retinopathy (DR) is a complication of diabetes and one of the leading causes of
vision loss worldwide. Despite extensive efforts to reduce visual impairment, the prevalence …

Diabetic retinopathy (DR) is the leading cause of blindness in industrialized countries.
Remarkable advances in the diagnosis and treatment of DR have been made during the …

Management of center-involving diabetic macular edema represents a real therapeutic
challenge. Diabetic macular edema is the leading cause of visual acuity impairment in …

Background Postoperative vitreous cavity haemorrhage (POVCH) is a significant
complication following vitrectomy for proliferative diabetic retinopathy (PDR). It delays visual …

Purpose: To systematically review and perform meta-analysis on the available randomized
controlled trial data for anti-vascular endothelial growth factor (anti-VEGF) agents in the …

Diabetic retinopathy (DR) is a leading cause of vision impairment and blindness in the
working-age population. The identification of vascular endothelial growth factor (VEGF) as a …

Background/aims To evaluate the efficacy of antivascular endothelial growth factor (anti-
VEGF) agents pretreatment before vitrectomy for patients with complicated proliferative …

Currently, controversies regarding the optimal time-point of anti-vascular endothelial growth
factor (VEGF) pretreatment before pars plana vitrectomy (PPV) for proliferative diabetic …

Tractional retinal detachment is an end-stage form of diabetic retinopathy that occurs when
contractile forces in the vitreous and neovascular tissue lead to the detachment of the …